# Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring

> **NCT06873828** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Yonsei University** · enrollment: 100 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DEVICE:** ATP-C135
- **DEVICE:** ATP-C75

## Key facts

- **NCT ID:** NCT06873828
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06873828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06873828, "Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06873828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*